Reference : La thoracoscopie médicale en pratique pneumologique: expérience du CHU de Liège
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/241103
La thoracoscopie médicale en pratique pneumologique: expérience du CHU de Liège
French
[en] Medical thoracoscopy in respiratory medicine: The Liège University Hospital experience
DUYSINX, Bernard mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Oncologie thoracique >]
HEINEN, Vincent mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de pneumologie - allergologie >]
Corhay, Jean-Louis mailto [Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques >]
VAILLANT, Frédérique mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de pneumologie - allergologie >]
Gomez, A. [Service de pneumologie, CHU de Sart-Tilman B35, Liège, B4000, Belgium]
Louis, Renaud mailto [Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie >]
2019
Revue des Maladies Respiratoires
Elsevier Masson SAS
36
688-696
Yes (verified by ORBi)
International
07618425
[en] Pleural effusion ; Pleural exploration ; Pleurisy ; Pneumothorax ; Thoracentesis ; Thoracoscopy
[en] Introduction: The incidence of pleural disease continues to increase worldwide. Medical thoracoscopy remains the standard method for exploration of the pleural cavity. Method: We report the retrospective evaluation, the efficacy and the observed complications in 1024 medical thoracoscopies undertaken in the University Hospital of Liège between 2000 and 2017. Results: In total, 100 pneumothoraces and 400 benign and 501 malignant pleural diseases were identified. The main indication for thoracoscopy remains the diagnosis of an exudative, lymphocytic pleural effusion of unknown aetiology after thoracocentesis. The diagnostic sensibility of thoracoscopy was 99.2% in distinguishing benign from malignant pleural disease. Talc pleurodesis was performed in 69.5% of the total population and in 66.1% of pleural effusions or thickening. Failure of pleurodesis was observed in 11% of the patients with recurrent pneumothorax and in 7.8% of neoplastic pleural effusion. We report a mortality of 0.6% in the 30 days post procedure, long duration of drainage in 8.3% and serious complications in 4.7%. In 22/1024 (2.1%) thoracoscopic evaluation was not feasible because of dense pleural fibrosis. Conclusion: Medical thoracoscopy is a safe, well-tolerated procedure with high accuracy in the diagnostic and therapeutic management of pleural disease. © 2019 SPLF
http://hdl.handle.net/2268/241103
10.1016/j.rmr.2019.02.007

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
DUYSINX 2019_La thoracoscopie médicale_Rev Mal Resp_ppediteur.pdfPublisher postprint558.07 kBRequest copy
Open access
DUYSINX 2019_La thoracoscopie médicale_Rev Mal Resp_OCR.pdfAuthor postprint489.89 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.